Rhumbline Advisers Grifols Sa Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Grifols Sa stock. As of the latest transaction made, Rhumbline Advisers holds 17,122 shares of GRFS stock, worth $148,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,122
Previous 15,914
7.59%
Holding current value
$148,961
Previous $100,000
52.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GRFS
# of Institutions
162Shares Held
140MCall Options Held
288KPut Options Held
389K-
Capital World Investors Los Angeles, CA21MShares$183 Million0.03% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA19.9MShares$173 Million2.11% of portfolio
-
Permian Investment Partners, LP New York, NY12.3MShares$107 Million16.06% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.1MShares$96.7 Million3.5% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny10.7MShares$93.3 Million0.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.91B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...